IMM — ImmuPharma Share News
0.000.00%
Brief: Immupharma Says Not Aware Of Any Reason For Share Price Movements
Response to Share Price Movement
UK's ImmuPharma rises on "groundbreaking" finding in autoimmune diseases
Brief: Immupharma Reports Breakthrough Findings Into Autoimmune Diseases
IMM at JP MORGAN CONFERENCE & BIOTECH SHOWCASE
Holding(s) in Company
Brief: ImmuPharma H1 net income GBP -400 thousand
Half-year Report
Holding(s) in Company
Holding(s) in Company
Notice of AGM & Annual Report & Accounts
Final Results
Realisation-c£1.5m on sale of shares in Incanthera
Holding(s) in Company
Immupharma At Bio: EQUITY 2024 12-14 May
Grant of Share Options
Brief: Immupharma Initiates New Intellectual Property Strategy
Incanthera provides Comm'l Update/Revenue F'casts
Grant of Share Options